top of page

Genetic medicines expert Emily Walsh Martin shares learnings from Day 2 of #ASGCT2024

Emily Walsh Martin covers regulatory comments from FDA's Peter Marks, scientific updates on prime and base editing, and more.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page